Immunomodulatory effects of Interleukin 2 in the circulation of melanoma patients and the added impact of VEGF inhibition with Ziv-aflibercept

被引：0
|
作者：
Khunger, Arjun [1 ]
Sarikonda, Ghanashyam [2 ]
Frankel, Paul [3 ]
Tsau, Jenn [2 ]
Alfonso, Zeni [2 ]
Gao, Jane [2 ]
Pahuja, Anil [2 ]
Vaupel, Christine [2 ]
Dakappagari, Naveen [2 ]
Tangri, Shabnam [2 ]
Tarhini, Ahmad [4 ,5 ]
机构：
[1] Mem Hosp West, Pembroke Pines, FL USA
[2] Navigate BioPharma Serv Inc, Carlsbad, CA USA
[3] City Hope Natl Med Ctr, Duarte, CA USA
[4] Emory Univ, Atlanta, GA 30322 USA
[5] Winship Comprehens Canc Ctr, Atlanta, GA USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P13
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Association of LpPLA2 activity with coronary and LV function in patients with coronary artery disease and coexistent rheumatoid arthritis: effects of Interleukin-1 inhibition
    Ikonomidis, I.
    Tzortzis, S.
    Tellis, C.
    Andreadou, I.
    Katsimbri, P.
    Paraskevaidis, I.
    Parissis, J.
    Anastasiou-Nana, M.
    Tselepis, A.
    Lekakis, J.
    EUROPEAN HEART JOURNAL, 2013, 34 : 118 - 119
  • [42] Effects of the administration of high-dose interleukin-2 on immunoregulatory cell subsets in patients with advanced melanoma and renal cell cancer (vol 13, pg 2100, 2007)
    van der Vliet, H. J.
    Koon, H. B.
    Yue, S. C.
    CLINICAL CANCER RESEARCH, 2007, 13 (11) : 3433 - 3433
  • [43] Clinical and immunologic effects of subcutaneously administered interleukin-12 and interferon alfa-2b: Phase I trial of patients with metastatic renal cell carcinoma or malignant melanoma
    Alatrash, G
    Hutson, TE
    Molto, L
    Richmond, A
    Nemec, C
    Mekhail, T
    Elson, P
    Tannenbaum, C
    Olencki, T
    Finke, J
    Bukowski, RM
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 2891 - 2900
  • [44] Immunomodulatory effects of high-dose and lowdose interferon α2b in patients with high-risk resected melanoma -: The E2690 laboratory corollary of Intergroup Adjuvant Trial E1690
    Kirkwood, JM
    Richards, T
    Zarour, HM
    Sosman, J
    Ernstoff, M
    Whiteside, TL
    Ibrahim, J
    Blum, R
    Wieand, S
    Mascari, R
    CANCER, 2002, 95 (05) : 1101 - 1112
  • [45] HDM2 Inhibition Augments the Antitumor and Antiangiogenic Effects of VEGF-R Antagonists by Suppressing SDF-1 Expression and Tumor Recruitment of CD11b/GR1+MDSC in RCC and Melanoma Xenografts
    Panka, D. J.
    Bhatt, R. S.
    Mier, J. W.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 41 - 42
  • [46] High dose bolus (HDB) interleukin-2 (IL2) and concurrent low dose ipilimumab followed sequentially by nivolumab in patients with advanced melanoma after failure of anti-PD1-based immunotherapy and BRAF-MEK inhibition
    Tarhini, Ahmad A.
    Eroglu, Zeynep
    Galuia, Mariem
    Eljilany, Islam
    Kalos, Denise
    Schell, Michael J.
    Tetteh, Leticia
    Abraham, Edith
    Richards, Allison
    Brohl, Andrew Scott
    Khushalani, Nikhil I.
    Markowitz, Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [47] CLINICAL AND IMMUNOMODULATORY EFFECTS OF COMBINATION IMMUNOTHERAPY WITH LOW-DOSE INTERLEUKIN-2 AND TUMOR-NECROSIS-FACTOR-ALPHA IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER - A PHASE-I TRIAL
    YANG, SC
    GRIMM, EA
    PARKINSON, DR
    CARINHAS, J
    FRY, KD
    MENDIGURENRODRIGUEZ, A
    LICCIARDELLO, J
    OWENSCHAUB, LB
    HONG, WK
    ROTH, JA
    CANCER RESEARCH, 1991, 51 (14) : 3669 - 3676
  • [48] In vivo effects of sequential granulocyte-macrophage colony stimulating factor (GM-CSF) and interleukin-2 (IL-2) on circulating dendritic cells (DC) in patients with surgically resected high risk cutaneous melanoma
    Hasskamp, Joanne H.
    Elias, E. George
    Zapas, John L.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2006, 26 (04) : 331 - 338
  • [49] In Vivo Effects of Sequential Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) and Interleukin-2 (IL-2) on Circulating Dendritic Cells (DC) in Patients with Surgically Resected High Risk Cutaneous Melanoma
    JOANNE H. HASSKAMP
    E. GEORGE ELIAS
    JOHN L. ZAPAS
    Journal of Clinical Immunology, 2006, 26 : 331 - 338
  • [50] In vivo effects of sequential granulocyte-macrophage colony stimulating factor (GM-CSF) and interleukin-2 (IL-2) on depressed peripheral blood dendritic cell (DC) counts in patients with stage IIB-IV melanoma
    Zapas, JL
    Hasskamp, J
    Beam, S
    Brown, S
    Elias, EG
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2004, 199 (03) : S81 - S81
12345